Page results
-
The service offers a holistic, multidisciplinary approach to the evaluation and treatment of bladder, bowel and sexual dysfunction in individuals with established and suspected neurological disorders.
-
This information is for patients who are having radiotherapy for a base of skull tumour. It explains what the treatment involves, describes side-effects you may experience during and after treatment, and how best to cope with them.
-
Our mission is to provide state-of-the-art, high-quality, evidence-based and patient-centred treatment for the management of all grades of endometriosis.
-
This page explains what you can expect before, during and after your treatment in chemotherapy daycare.
-
The spasticity service at NHNN offers a comprehensive, responsive multidisciplinary service to adults with spasticity associated with any neurological condition.
-
Hypopharyngeal cancer is a rare type of cancer that affects the inlet to the oesophagus (gullet).
-
Nasopharyngeal cancer is a rare type of cancer that affects the part of the throat connecting the back of the nose to the back of the mouth (the pharynx).
-
You can get your COVID-19 vaccine this weekend at venues across London
-
There is industrial action by resident doctors (formerly known as junior doctors) from 7am on Wednesday 17 December until 7am on Monday 22 December.
-
UCLH has over 15 years’ experience as a leading centre for the treatment of mesh complications and mesh removal.
File results
-
FOI/2022/0531 - Operating theatres in Trust
-
FOI/2022/0533 - Pathology service carrying out PCR testing for SARS-CoV2
-
FOI/2022/0539 - Pharmacological choices made for patients undergoing joint replacement surgery
-
FOI/2022/0557 - Patients treated with Visudyne (verteporfin)
-
FOI/2022/0563 - Ambulatory cardiac monitoring
-
FOI/2022/0544 - Wards/ departments that provide services to 0-17 year-olds
-
FOI/2022/0545 - Criteria used in determining acceptance of GP referrals for osteoporosis treatment, and for priorisation of osteoporosis appointments
-
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments